Uniqure NV (NASDAQ:QURE), a leader in human gene therapy, today announced the appointment of Dan Soland as the new Chief Executive Officer of the …
This week, analysts expressed bullish sentiments on both Uniqure NV (NASDAQ:QURE) and Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) in light of new drug …
Analysts from Piper Jaffray and Cowen weigh in on the Netherlands-based biotechnology company Uniqure NV (NASDAQ:QURE) and technology company Supercom Ltd (NASDAQ:SPCB), as quarterly reports sent shares of both …
Uniqure NV (NASDAQ:QURE), a leader in human gene therapy, today announced financial results for the third quarter and nine months ending September 30, 2015, …
Here’s what to watch for this week from GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), Avago Technologies Ltd (NASDAQ:AVGO), Ambarella Inc (NASDAQ:AMBA), and Uniqure NV …
Uniqure NV (NASDAQ:QURE)’s presentation of 1-year follow-up data from patients with Sanfilippo B (MPS IIIB) and treated with the gene therapy AMT-110 is …
In a research note issued today, Chardan analyst Gbola Amusa maintained a Buy rating on shares of Uniqure NV (NASDAQ:QURE), and reduced the price target to …
In a research report released Sunday, Oppenheimer analyst Christopher Marai maintained an Outperform rating on Uniqure NV (NASDAQ:QURE) with a price target of $47, …
Roth Capital analyst Debjit Chattopadhyay was out pounding the table on Uniqure NV (NASDAQ:QURE) Friday, reiterating a Buy rating and price target of $38 …
Piper Jaffray analyst Joshua Schimmer weighed in today with his opinions on Uniqure NV (NASDAQ:QURE) after the company released its first quarter earnings and updated …
